MentionFox
Home › Stakes › Dr Reddy'S Laboratories Ltd
5%+ stakes · Schedule 13D and 13G

Dr Reddy'S Laboratories Ltd: 5%+ holders

Who has reported owning 5% or more of Dr Reddy'S Laboratories Ltd, from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more1
Filings1
Latest filing2025-09-18

Dr Reddy'S Laboratories Ltd has 1 Schedule 13D or 13G filing on record since 2025-09-18. 1 holder's latest filing reports 5% or more of american depositary shares, each representing one equity share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
G.V. Prasad13.58%108,813,010SCHEDULE 13D/A, 2025-09-182025-09-17

Purpose of Transaction (Item 4)

G.V. Prasad

Item 4 of the Amended Schedule 13D is hereby amended and supplemented as follows: On September 17, 2025, Mr. G.V. Prasad transferred 96,095,920 Post-Split Shares to GVP Family Trust and Mr. K. Satish Reddy transferred 75,630,620 Post-Split Shares to VSD Family Trust. These transfers of shares were done for estate planning purposes, and to implement family succession arrangements and planning for a smooth and streamlined transfer of family assets and businesses.Item 4 of the SCHEDULE 13D/A filed 2025-09-18

Timeline

FiledHolderPercentFiling
2025-09-18G.V. Prasad13.58%SCHEDULE 13D/A

Tools for this story

Each opens in a new tab, filled in for Dr Reddy'S Laboratories Ltd. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/dr-reddys-laboratories
Last updated 2026-09-27
Primary record: SEC filing
Dr Reddy'S Laboratories Ltd 5%+ holders: 1 at 5% or more, largest G.V. Prasad 13.58%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/dr-reddys-laboratories